NOX4 and cardiac hypertrophy: The cardiomyocyte-specific overexpression of human NOX4, at higher levels that recapitulate upregulation in response to AngII, was sufficient to induce myocardial ROS and fibrosis comparable to AngII treatment, but in the absence of cardiac hypertrophy [98].